Supplemental material
Cancer Biology & Therapy
Volume 13, 2012 - Issue 9
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related Research Data
Transforming Growth Factor-β Receptor Blockade Augments the Effectiveness of Adoptive T-Cell Therapy of Established Solid Cancers
Source:
American Association for Cancer Research (AACR)
Acute wounds accelerate tumorigenesis by a T cell-dependent mechanism.
Source:
American Association for Cancer Research (AACR)
Neoadjuvant Vaccination Provides Superior Protection against Tumor Relapse following Surgery Compared with Adjuvant Vaccination
Source:
American Association for Cancer Research (AACR)
Soluble Type II Transforming Growth Factor-β Receptor Inhibits Established Murine Malignant Mesothelioma Tumor Growth by Augmenting Host Antitumor Immunity
Source:
American Association for Cancer Research (AACR)
Effect of Dominant Negative Transforming Growth Factor-β Receptor Type II on Cytotoxic Activity of RAW 264.7, a Murine Macrophage Cell Line
Source:
American Association for Cancer Research (AACR)
Impact of minimal tumor burden on antibody response to vaccination
Source:
Springer Science and Business Media LLC
Clinical and pharmacodynamic evaluation of metronomic cyclophosphamide, celecoxib, and dexamethasone in advanced hormone-refractory prostate cancer.
Source:
American Association for Cancer Research (AACR)
In vivo internal tumor illumination by telomerase-dependent adenoviral GFP for precise surgical navigation
Source:
United States National Academy of Sciences
Neoadjuvant in situ gene-mediated cytotoxic immunotherapy improves postoperative outcomes in novel syngeneic esophageal carcinoma models.
Source:
Springer Science and Business Media LLC
Cyclooxygenase-2 Inhibitors in Tumorigenesis (Part II)
Source:
Oxford University Press (OUP)
Transforming growth factor-beta and the immune response to malignant disease.
Source:
American Association for Cancer Research (AACR)
The multiple uses of fluorescent proteins to visualize cancer in vivo
Source:
Springer Science and Business Media LLC
The potential risk of tumor progression after use of dehydrated human amnion/chorion membrane allograft in a positive margin resection model:
Source:
SAGE Publishing
Partial, but not Complete, Tumor-Debulking Surgery Promotes Protective Antitumor Memory when Combined with Chemotherapy and Adjuvant Immunotherapy
Source:
American Association for Cancer Research (AACR)
The importance of the tumor microenvironment in the therapeutic management of cancer
Source:
Informa UK Limited
Evaluation of Aminolevulinic Acid-Derived Tumor Fluorescence Yields Disparate Results in Murine and Spontaneous Large Animal Models of Lung Cancer
Source:
Springer Science and Business Media LLC
Systemic blockade of transforming growth factor-beta signaling augments the efficacy of immunogene therapy.
Source:
American Association for Cancer Research (AACR)
Systemic Inhibition of Transforming Growth Factor-β in Glioma-Bearing Mice Improves the Therapeutic Efficacy of Glioma-Associated Antigen Peptide Vaccines
Source:
American Association for Cancer Research (AACR)
A mouse model of human oral-esophageal cancer
Source:
American Society for Clinical Investigation
Synergistic enhancement of CD8+ T cell-mediated tumor vaccine efficacy by an anti-transforming growth factor-beta monoclonal antibody.
Source:
American Association for Cancer Research (AACR)
Linking provided by
